Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | March 2011 Supplement

Expert Roundtable

Featuring Anthony J. Comerota, MD; Marc H. Glickman, MD, FACS; Thomas A. Hennebry, MB BCh BAO, FACC, FSCAI; Charles Pollack, MD, MA; and Mahmood K. Razavi, MD

Sponsored by Gore & Associates

evt | Article | June 2014 Supplement

GORE® ACUSEAL Vascular Graft and Early Cannulation

Perspective on the potential patient care paradigm shift.

By Marc H. Glickman, MD

Sponsored by Gore & Associates

evt | Article | June 2014 Supplement

GORE® ACUSEAL Vascular Graft and Early Cannulation

Perspective on the potential patient care paradigm shift.

By Marc H. Glickman, MD

evt | Article | March 2011 Supplement

Treating DVT Within a Health Care System

A systematic approach to health care delivery for patients with deep vein thrombosis.

By Marc H. Glickman, MD, FACS, and Richard J. DeMasi, MD, FACS, RVT

Advertisement

Advertisement

evt | News | March 30, 2014

CryoLife to Distribute Hancock Jaffe's ProCol Vascular Bioprosthesis for Hemodialysis Access

March 27, 2014—CryoLife, Inc. (Kennesaw, GA) announced that it has acquired the exclusive worldwide distribution rights for the ProCol vascular bioprosthesis from Hancock Jaffe Laboratories, Inc. (Irvine, CA), and it has the right to acquire the ProCol product line from Hancock Jaffe, beginning 24 months after execution of the agreement.

evt | News | February 11, 2021

Hancock Jaffe Prepares for the VenoValve United States Pivotal Trial

February 11, 2021—Hancock Jaffe Laboratories, Inc. announced it has successfully completed a public offering of its securities.

Sponsored by TriVascular, Inc.

evt | Article | September 2015 Supplement

Limb Patency Outcomes in Contemporary Data

A review of peer-reviewed publications on real-world limb patency rates.

By George N. Kouvelos, MD; Athanasios Katsargyris, MD; and Eric Verhoeven, MD, PhD

evt | Article | June 2021

Panel Discussion: DCBs in AV Access From Trials to the Real World

Evaluating drug-coated balloon applicability and adoptability in the dialysis access setting.

With Andrew Holden, MBChB, FRANZCR, EBIR; Narayan Karunanithy, MRCS, FRCR, FCIRSE; Scott O. Trerotola, MD; and Haimanot (Monnie) Wasse, MD, MPH, FASN, FASDIN


1

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button